PubRank

Mauro Ferrari

Author PubWeight™ 197.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008 3.78
2 Intravascular delivery of particulate systems: does geometry really matter? Pharm Res 2008 3.13
3 Clinical proteomics: written in blood. Nature 2003 2.81
4 Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010 2.80
5 Nanomedicine--challenge and perspectives. Angew Chem Int Ed Engl 2009 2.74
6 Nanotechnologies for biomolecular detection and medical diagnostics. Curr Opin Chem Biol 2006 2.74
7 Seven challenges for nanomedicine. Nat Nanotechnol 2008 2.59
8 Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast. Nat Nanotechnol 2010 2.17
9 Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 2012 1.85
10 Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 2007 1.72
11 Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release 2011 1.72
12 Tailored porous silicon microparticles: fabrication and properties. Chemphyschem 2010 1.71
13 Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 2009 1.63
14 The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009 1.63
15 What does physics have to do with cancer? Nat Rev Cancer 2011 1.59
16 Morphologic instability and cancer invasion. Clin Cancer Res 2005 1.55
17 Nanogeometry: beyond drug delivery. Nat Nanotechnol 2008 1.54
18 Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res 2009 1.53
19 Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 2010 1.49
20 Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation. J Math Biol 2008 1.48
21 Osmotic pressure beyond concentration restrictions. J Phys Chem B 2007 1.46
22 Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc Chem Res 2011 1.45
23 Biotechnology apprenticeship for secondary-level students: teaching advanced cell culture techniques for research. Cell Biol Educ 2002 1.45
24 Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. Cell Biochem Funct 2012 1.44
25 T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A 2003 1.37
26 Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 2007 1.36
27 Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors. AIP Adv 2012 1.35
28 Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice. Adv Funct Mater 2012 1.35
29 Mitotic trafficking of silicon microparticles. Nanoscale 2009 1.35
30 A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep 2013 1.33
31 Cellular association and assembly of a multistage delivery system. Small 2010 1.32
32 Biodegradable porous silicon barcode nanowires with defined geometry. Adv Funct Mater 2010 1.31
33 Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J Biomed Mater Res A 2010 1.31
34 Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev Anticancer Ther 2006 1.30
35 Multiparameter computational modeling of tumor invasion. Cancer Res 2009 1.28
36 Enabling individualized therapy through nanotechnology. Pharmacol Res 2010 1.28
37 Nanomedicine in cancer therapy: innovative trends and prospects. Cancer Sci 2011 1.27
38 Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest 2014 1.26
39 The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials 2012 1.25
40 Interstitial stress and fluid pressure within a growing tumor. Ann Biomed Eng 2003 1.25
41 Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta 2010 1.23
42 Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases. Trends Pharmacol Sci 2010 1.22
43 Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery. Clin Cancer Res 2013 1.21
44 Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small 2010 1.19
45 Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting. PLoS One 2010 1.19
46 Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater 2011 1.16
47 Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A 2009 1.16
48 Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano 2010 1.16
49 Design of bio-mimetic particles with enhanced vascular interaction. J Biomech 2009 1.15
50 Intracellular trafficking of silicon particles and logic-embedded vectors. Nanoscale 2010 1.15
51 Laparoscopic treatment of splenic artery aneurysms. J Vasc Surg 2009 1.13
52 E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow. Adv Mater 2011 1.12
53 Nanotechnology for breast cancer therapy. Biomed Microdevices 2009 1.10
54 Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome. Proteomics 2010 1.08
55 Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials 2012 1.07
56 Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture. PLoS One 2012 1.07
57 The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology. Ann Biomed Eng 2008 1.07
58 Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment. Cancer Lett 2012 1.06
59 Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget 2011 1.06
60 Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy. Small 2013 1.05
61 Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles. Mol Imaging 2011 1.04
62 Nanotechnology and tumor imaging: seizing an opportunity. Mol Imaging 2004 1.04
63 Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. Biomaterials 2013 1.03
64 Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. Circulation 2003 1.02
65 Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs. Contrast Media Mol Imaging 2012 1.02
66 Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J Control Release 2005 1.02
67 An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. Adv Genet 2010 1.00
68 Modulating cellular adhesion through nanotopography. Biomaterials 2009 0.99
69 Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A 2012 0.99
70 A low-voltage electrokinetic nanochannel drug delivery system. Lab Chip 2011 0.99
71 A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery. Lab Chip 2010 0.99
72 Adhesion of microfabricated particles on vascular endothelium: a parametric analysis. Ann Biomed Eng 2004 0.99
73 Fractionation of serum components using nanoporous substrates. Bioconjug Chem 2006 0.98
74 Mesoporous silica as a membrane for ultra-thin implantable direct glucose fuel cells. Lab Chip 2011 0.98
75 Nanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasma. J Proteome Res 2006 0.98
76 Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44. Biochemistry 2010 0.96
77 The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnology 2008 0.95
78 Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. Small 2012 0.95
79 Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration. Pharm Res 2010 0.94
80 Vectoring siRNA therapeutics into the clinic. Nat Rev Clin Oncol 2010 0.94
81 Abdominal aortic aneurysm: contrast-enhanced US for missed endoleaks after endoluminal repair. Radiology 2004 0.94
82 Delivery of gene silencing agents for breast cancer therapy. Breast Cancer Res 2013 0.94
83 Modeling of nanotherapeutics delivery based on tumor perfusion. New J Phys 2013 0.94
84 Controlled-release microchips. Expert Opin Drug Deliv 2006 0.94
85 Multistage Mesoporous Silicon-based Nanocarriers: Biocompatibility with Immune Cells and Controlled Degradation in Physiological Fluids. Controll Release Newsl 2008 0.93
86 In silico vascular modeling for personalized nanoparticle delivery. Nanomedicine (Lond) 2012 0.93
87 Molecular-targeted nanotherapies in cancer: enabling treatment specificity. Mol Oncol 2011 0.93
88 Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells. J Microencapsul 2014 0.92
89 Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles. Mol Imaging 2011 0.92
90 Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteins. Nanoscale 2010 0.92
91 Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 2007 0.91
92 Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers. Cancer Lett 2012 0.90
93 Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networks. Int J Nanomedicine 2011 0.90
94 Monitoring the progression of metastatic breast cancer on nanoporous silica chips. Philos Trans A Math Phys Eng Sci 2012 0.90
95 Degradation and biocompatibility of multistage nanovectors in physiological systems. J Biomed Mater Res A 2013 0.90
96 Selective binding and enrichment for low-molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles. Proteomics 2006 0.90
97 Silicon micro- and nanofabrication for medicine. Adv Healthc Mater 2013 0.90
98 Leveraging nanochannels for universal, zero-order drug delivery in vivo. J Control Release 2013 0.89
99 Direct evidence for catalase and peroxidase activities of ferritin-platinum nanoparticles. Biomaterials 2010 0.89
100 Prospects for microtechnology and nanotechnology in bioengineering of replacement microvessels. Arch Pathol Lab Med 2002 0.88
101 Biomedical nanotechnology for cancer. Med Clin North Am 2007 0.88
102 Physicochemically modified silicon as a substrate for protein microarrays. Biomaterials 2006 0.88
103 Duodenal duplication cyst causing severe pancreatitis: imaging findings and pathological correlation. World J Gastroenterol 2006 0.88
104 A new preoperative predictor of outcome in ruptured abdominal aortic aneurysms: the time before shock (TBS). Ann Vasc Surg 2009 0.88
105 Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy. Adv Healthc Mater 2014 0.87
106 nan'o.tech.nol'o.gy n. Nat Nanotechnol 2006 0.87
107 Case report of a successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and MRSA/vancomycin-resistant Enterococcus faecium cholecystitis by daptomycin. Antimicrob Agents Chemother 2011 0.87
108 Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small 2012 0.87
109 Evaluation of cell function upon nanovector internalization. Small 2012 0.87
110 Sustained zero-order release of intact ultra-stable drug-loaded liposomes from an implantable nanochannel delivery system. Adv Healthc Mater 2013 0.86
111 Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells. Biomaterials 2013 0.85
112 Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay. Cancer Lett 2012 0.85
113 Molecular modeling of glucose diffusivity in silica nanochannels. J Nanosci Nanotechnol 2009 0.85
114 Gated and near-surface diffusion of charged fullerenes in nanochannels. ACS Nano 2011 0.85
115 Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression. J Transl Med 2013 0.85
116 Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells. Nanomedicine 2011 0.85
117 Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate. Stem Cells Dev 2015 0.84
118 Nanodevices in diagnostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010 0.84
119 Application of physicochemically modified silicon substrates as reverse-phase protein microarrays. J Proteome Res 2009 0.84
120 Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip. Biomicrofluidics 2011 0.84
121 Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts. Anticancer Res 2007 0.84
122 The molecular analysis of breast cancer utilizing targeted nanoparticle based ultrasound contrast agents. Technol Cancer Res Treat 2005 0.84
123 Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1. Stem Cells 2014 0.84
124 Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system. Pharm Res 2011 0.84
125 Safety of Nanoparticles in Medicine. Curr Drug Targets 2015 0.83
126 Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health. Anal Bioanal Chem 2012 0.83
127 Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater 2014 0.83
128 A case of concomitant occurrence of solitary fibrous tumor and urothelial high-grade invasive carcinoma of the urinary bladder. Int J Surg Pathol 2013 0.83
129 Probing the mechanical properties of TNF-α stimulated endothelial cell with atomic force microscopy. Int J Nanomedicine 2011 0.83
130 Multiscale patterning of a biomimetic scaffold integrated with composite microspheres. Small 2014 0.82
131 Hesperetin: an inhibitor of the transforming growth factor-β (TGF-β) signaling pathway. Eur J Med Chem 2012 0.82
132 Characterization of a nanogland for the autotransplantation of human pancreatic islets. Lab Chip 2013 0.82
133 Mixed reality for robotic treatment of a splenic artery aneurysm. Surg Endosc 2009 0.82
134 Low molecular weight protein enrichment on mesoporous silica thin films for biomarker discovery. J Vis Exp 2012 0.82
135 Fast membrane osmometer as alternative to freezing point and vapor pressure osmometry. Anal Chem 2008 0.81
136 Type II lumbar endoleaks: hemodynamic differentiation by contrast-enhanced ultrasound scanning and influence on aneurysm enlargement after endovascular aneurysm repair. J Vasc Surg 2005 0.81
137 Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol 2014 0.81
138 Porous silicon advances in drug delivery and immunotherapy. Curr Opin Pharmacol 2013 0.81
139 Value of multidetector computed tomography image segmentation for preoperative planning in general surgery. Surg Endosc 2011 0.81
140 Endovascular repair of abdominal aortic aneurysms: analysis of aneurysm volumetric changes at mid-term follow-up. Cardiovasc Intervent Radiol 2005 0.81
141 Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother 2006 0.81
142 The physiology of cardiovascular disease and innovative liposomal platforms for therapy. Int J Nanomedicine 2013 0.81
143 Efficacy and safety of a novel vascular closure device (Glubran 2 seal) after diagnostic and interventional angiography in patients with peripheral arterial occlusive disease. Cardiovasc Intervent Radiol 2012 0.80
144 Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. Curr Drug Targets 2015 0.80
145 Validated RP-HPLC method for the simultaneous analysis of gemcitabine and LY-364947 in liposomal formulations. Curr Drug Targets 2013 0.80
146 Multiscale modeling of circular and elliptical particles in laminar shear flow. IEEE Trans Biomed Eng 2011 0.80
147 Device for rapid and agile measurement of diffusivity in micro- and nanochannels. Anal Chem 2011 0.80
148 Distribution of innate ability for surgery amongst medical students assessed by an advanced virtual reality surgical simulator. Surg Endosc 2014 0.80
149 Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm. J Steroid Biochem Mol Biol 2004 0.79
150 Enhanced microcontact printing of proteins on nanoporous silica surface. Nanotechnology 2010 0.79
151 Circulating proteolytic products of carboxypeptidase N for early detection of breast cancer. Clin Chem 2013 0.79
152 Evaluation of the proximal aortic neck enlargement following endovascular repair of abdominal aortic aneurysm: 3-years experience. Eur Radiol 2003 0.79
153 Opportunities for nanotechnology-based innovation in tissue proteomics. Biomed Microdevices 2004 0.79
154 Multiscale modeling of protein transport in silicon membrane nanochannels. Part 1. Derivation of molecular parameters from computer simulations. Biomed Microdevices 2006 0.79
155 Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer. Mini Rev Med Chem 2015 0.78
156 Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane. Nanoscale 2015 0.78
157 Ultrasonographic surveillance with selective CTA after endovascular repair of abdominal aortic aneurysm. J Endovasc Ther 2009 0.78
158 Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging. Cancer Imaging 2008 0.78
159 Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions. Nanoscale 2016 0.78
160 Release of biologically functional interferon-alpha from a nanochannel delivery system. Biomed Microdevices 2005 0.78
161 Dynamic model of biomolecular diffusion through two-dimensional nanochannels. J Phys Chem B 2005 0.78
162 Nanotexture Optimization by Oxygen Plasma of Mesoporous Silica Thin Film for Enrichment of Low Molecular Weight Peptides Captured from Human Serum. Sci China Chem 2010 0.78
163 Bioengineering nanotechnology: towards the clinic. Nanotechnology 2011 0.77
164 Computer guidance system for single-incision bimanual robotic surgery. Comput Aided Surg 2012 0.77
165 Size of the nanovectors determines the transplacental passage in pregnancy: study in rats. Am J Obstet Gynecol 2011 0.77
166 Noninvasive diagnosis of incomplete endovascular aneurysm repair: D-dimer assay to detect type I endoleaks and nonshrinking aneurysms. J Endovasc Ther 2002 0.77
167 Polyarginine induces an antitumor immune response through binding to toll-like receptor 4. Small 2013 0.77
168 How does a surgeon's brain buzz? An EEG coherence study on the interaction between humans and robot. Behav Brain Funct 2013 0.77
169 Live-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane. FEBS Lett 2013 0.77
170 Design maps for scaffold constructs in bone regeneration. Biomed Microdevices 2013 0.76
171 Micropatterning of endothelial cells by guided stimulation with angiogenic factors. Biosens Bioelectron 2004 0.76
172 A portrait of nanomedicine and its bioethical implications. J Law Med Ethics 2012 0.76
173 Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy. J Cell Physiol 2015 0.76
174 Conference scene: nanotechnology and medicine: the next big thing is really small. Nanomedicine (Lond) 2009 0.76
175 Antibody-free detection of Mycobacterium tuberculosis antigen using customized nanotraps. Anal Chem 2014 0.76
176 Mesoporous silicon particles for sustained gene silencing. Methods Mol Biol 2013 0.76
177 Sporadic or familial head neck paragangliomas enrolled in a single center: clinical presentation and genotype/phenotype correlations. Head Neck 2012 0.76
178 Multiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model. Biomed Microdevices 2006 0.76
179 Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB. ACS Appl Mater Interfaces 2017 0.76
180 Transport Oncophysics in silico, in vitro, and in vivo. Preface. Phys Biol 2014 0.75
181 Shaping the micromechanical behavior of multi-phase composites for bone tissue engineering. Acta Biomater 2010 0.75
182 Cardiovascular nanomedicine: a posse ad esse. Methodist Debakey Cardiovasc J 2012 0.75
183 The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation 2016 0.75
184 Preparation, characterization, and cellular associations of silicon logic-embedded vectors. Methods Enzymol 2012 0.75
185 Identification of an inhibitory mechanism of luteolin on the insulin-like growth factor-1 ligand-receptor interaction. Chembiochem 2013 0.75
186 Nanotechnologies and regenerative medical approaches for space and terrestrial medicine. Aviat Space Environ Med 2012 0.75
187 Mass partitioning effects in diffusion transport. Phys Chem Chem Phys 2015 0.75
188 Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles. Nanoscale 2017 0.75
189 Object-oriented design tools for supramolecular devices and biomedical nanotechnology. Ann N Y Acad Sci 2004 0.75
190 Straight talk with... Mauro Ferrari. Interviewed by Jon Evans. Nat Med 2009 0.75
191 Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia. Vasc Endovascular Surg 2006 0.75
192 Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions. Int J Low Extrem Wounds 2012 0.75
193 Mechanical spectral signatures of malignant disease? A small-sample, comparative study of continuum vs. nano-biomechanical data analyses. Dis Markers 2002 0.75
194 Cognitive impairment and polidistrectual atherosclerotic disease in chylomicronemia syndrome: a case report. Transfus Apher Sci 2013 0.75
195 Self-assembled zinc/copper hydroxide carbonates with tunable hierarchical nanostructure. J Nanosci Nanotechnol 2011 0.75
196 Integration of biomechanical parameters in tetrahedral mass-spring models for virtual surgery simulation. Conf Proc IEEE Eng Med Biol Soc 2011 0.75
197 Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane model. Curr Drug Targets 2013 0.75
198 Biomarker Signature Discovery from Mass Spectrometry Data. IEEE/ACM Trans Comput Biol Bioinform 2015 0.75
199 Hope in cancer patients: the relational domain as a crucial factor. Tumori 2015 0.75
200 Transcutaneous gases determination in diabetic critical limb ischemia. Diabetes Care 2005 0.75
201 Patient-specific ultrasound liver phantom: materials and fabrication method. Int J Comput Assist Radiol Surg 2014 0.75
202 Methodist Debakey Cardiovascular Journal offers special thanks to guest editors Biana Godin and Mauro Ferrari. Methodist Debakey Cardiovasc J 2012 0.75
203 Characterization of controlled bone defects using 2D and 3D ultrasound imaging techniques. Phys Med Biol 2010 0.75
204 EndoCAS (center for computer-assisted surgery). J Surg Educ 2014 0.75
205 Patient-specific surgical simulator for the pre-operative planning of single-incision laparoscopic surgery with bimanual robots. Comput Aided Surg 2012 0.75
206 Patient specific surgical simulator for the evaluation of the movability of bimanual robotic arms. Stud Health Technol Inform 2011 0.75